在治疗中使用孤儿药物 - - 综述
1Department of Neuropediatrics, Universital Hospital Bonn, Venusberg-Campus 1, 53127 Bonn, Germany. Member of the European Reference Network (ERN) EpiCARE, Germany.
Epilepsy & behavior : E&B
|January 18, 2025
概括
针对罕见疾病的孤儿药物开发面临诸如高成本和有限数据等挑战. 创新的试验设计对于推进等疾病的治疗方法至关重要,特别是发育性和性脑病变.
科学领域:
- 药理学 药理学是指药理学的学科.
- 罕见疾病 罕见疾病
- 临床试验 临床试验
背景情况:
- 孤儿药物激励罕见疾病治疗的发展,由食品和药物管理局 (FDA) 和欧洲药品管理局 (EMA) 根据流行率值进行指定.
- 激励措施包括降低成本和市场排他性,但高开发费用,有限的预审批数据和药物定价仍然是重大障碍.
- 目前针对的孤儿药物批准针对特定的综合征,留下了大量未满足的需求,特别是对于发育和脑病变.
研究的目的:
- 审查目前为罕见疾病开发孤儿药物的情况.
- 确定孤儿药物开发的挑战和未满足的需求,特别是针对综合征.
- 突出创新的试验设计在推进孤儿药物疗法的重要性.
主要方法:
- 审查现有的文献和关于孤儿药物名称和批准的监管数据.
- 分析目前在美国和欧盟批准的治疗的孤儿药物.
- 识别开发中的挑战,审批后的监测和医疗保健系统的影响.
主要成果:
- 三种抗发作药物获得欧盟孤儿药物批准,四种获得美国批准,针对四种综合征.
- 尽管获得批准,但仍然存在大量未满足的需求,特别是对于发育性和性脑病变.
- 高昂的开发成本,数据限制和医疗保健系统的财务负担是持续存在的挑战.
结论:
- 孤儿药激励措施旨在促进罕见疾病治疗,但面临着持续的障碍.
- 目前针对的孤儿药物批准不足,这凸显了严重的未满足需求.
- 创新的临床试验设计对于加速开发和批准用于罕见神经疾病的孤儿药物至关重要.
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
230
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
230
01:14Antiepileptic Drugs: Glutamate Antagonists
274
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
274
01:24Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
317
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
317
01:08Antiepileptic Drugs: Sodium Channel Blockers
379
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
379